Drug development
The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.
The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.
News innovation
Eckert & Ziegler: Record year 2024 with new all-time highs
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) achieved a new record in the 2024 financial year with sales of € 295.8 million based on the preliminary annual financial statements*. Compared to the pr...
more ...“Jugend forscht” at Campus Berlin-Buch
From better 3D printers for biological structures to soil remediation with microorganisms – in the 60th round of “Jugend forscht,” regional students presented their exciting research projects on the B...
more ...U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer Therapy
225Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma
more ...Events Campus
03.04.2025, 09:15
Girls‘ Day am Max Delbrück Center : "IT Girls in der Biomedizin - Was macht eine Informatikerin in der Gesundheitsforschung?"
Wir nehmen Euch für einen Tag mit in unsere Labore! Unsere Azubis, Forscherinnen und IT-Fachfrauen zeigen Euch ihren Berufsalltag und erzählen Euch warum sie ihren Beruf gewählt haben, wie ihr Weg dah...
more ...11.04.2025, 17:00
Campus Konzert „Meisterhafte Musik“ mit Nachwuchstalenten der Internationalen Musikakademie
Junge Talente zwischen 13 und 17 Jahren spielen Werke für Violine, Violoncello und Klavier von Beethoven, Chopin, Bruch, Liszt, Elgar und anderen.
more ...29.04.2025, 16:00
Krebsprävention durch Ernährung und körperliche Aktivität: Wie kommen wir zu wissenschaftlich fundierten Erkenntnissen?
Online-Kurs für Lehrkräfte mit Katharina Nimptsch
more ...
